C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus

Clicks: 311
ID: 267170
2001
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Elevated levels of CRP and IL-6 predict the development of type 2 DM. These data support a possible role for inflammation in diabetogenesis.
Reference Key
ad2001jamac-reactive Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Pradhan AD;Manson JE;Rifai N;Buring JE;Ridker PM;;
Journal JAMA
Year 2001
DOI
DOI not found
URL
https://www.ncbi.nlm.nih.gov/pubmed/11466099
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine logistic models research support non-u.s. gov't u.s. gov't female middle aged Prospective Studies P.H.S. Clinical Trial Randomized Controlled Trial statistics nonparametric multivariate analysis risk diabetes mellitus biomarkers / blood interleukin-6 / blood* pmid:11466099 doi:10.1001/jama.286.3.327 a d pradhan j e manson p m ridker c-reactive protein / metabolism* type 2 / epidemiology type 2 / etiology* type 2 / immunology

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.